Alain Dervaux
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
Papers in
-
- Schizophrenia research and treatment 17
- Bipolar Disorder and Treatment 4
- Pharmacology 18
- Cannabis and Cannabinoid Research 18
- Co-authors
- Xavier Laqueille (45 shared papers)Marie‐Odile Krebs (23 shared papers)Jean‐Pierre Olié (6 shared papers)Marie‐Chantal Bourdel (12 shared papers)H. Löo (4 shared papers)François Bayle (6 shared papers)Anne Gut (2 shared papers)M F Poirier (1 shared paper)
- Journals
- European Psychiatry (8 papers)Schizophrenia Research (5 papers)American Journal of Psychiatry (5 papers)European Neuropsychopharmacology (5 papers)The Lancet (4 papers)
- Partner nations
- FranceUnited StatesParaguay
In The Last Decade
Alain Dervaux
87 papers receiving 789 citations
Peers
Comparison fields: 5 of 69
- Psychiatry and Mental health 340
- Pharmacology 135
- Clinical Psychology 132
- Epidemiology 164
- Cellular and Molecular Neuroscience 51
Countries citing papers authored by Alain Dervaux
This map shows the geographic impact of Alain Dervaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Dervaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Dervaux more than expected).
Fields of papers citing papers by Alain Dervaux
This network shows the impact of papers produced by Alain Dervaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Dervaux. The network helps show where Alain Dervaux may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain Dervaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 134 | |
| 2 | 2001 | 123 | |
| 3 | [Cannabis and schizophrenia: demographic and clinical correlates]. | 2003 | 51 |
| 4 | 2010 | 50 | |
| 5 | 2008 | 48 | |
| 6 | 2019 | 32 | |
| 7 | 2004 | 26 | |
| 8 | 2008 | 25 | |
| 9 | 2010 | 22 | |
| 10 | 2010 | 22 | |
| 11 | 2010 | 22 | |
| 12 | 2005 | 20 | |
| 13 | 2016 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2012 | 17 | |
| 16 | 2007 | 16 | |
| 17 | 2005 | 15 | |
| 18 | 2005 | 12 | |
| 19 | [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case]. | 2001 | 11 |
| 20 | 2007 | 10 |
About Alain Dervaux
Alain Dervaux is a scholar working on Psychiatry and Mental health, Pharmacology, Epidemiology, Clinical Psychology and Public Health, Environmental and Occupational Health, having authored 100 papers that have together received 885 indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (27 papers), Cannabis and Cannabinoid Research (18 papers), Schizophrenia research and treatment (17 papers), Opioid Use Disorder Treatment (8 papers), Smoking Behavior and Cessation (7 papers), Alcoholism and Thiamine Deficiency (4 papers), Bipolar Disorder and Treatment (4 papers) and Prion Diseases and Protein Misfolding (3 papers). The work is most often cited by research in Psychiatry and Mental health (340 citations), Pharmacology (135 citations), Clinical Psychology (132 citations), Epidemiology (164 citations) and Cellular and Molecular Neuroscience (51 citations). Alain Dervaux has collaborated with scholars based in France, United States and Paraguay. Frequent co-authors include Xavier Laqueille, Marie‐Odile Krebs, Jean‐Pierre Olié, Marie‐Chantal Bourdel, H. Löo, François Bayle, Anne Gut, M F Poirier, Céline Goldberger and Amine Benyamina. Their work appears in journals such as European Psychiatry, Schizophrenia Research, American Journal of Psychiatry, European Neuropsychopharmacology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.